NeuroGeneces
Techstars '21Santa Fe, US · Founded 2021 · Delaware corporation · 16 employees on LinkedIn · 1 known investors
NeuroGevity develops a sleep headband with biometric sensors and AI algorithms to assess brain health and detect neurophysiological biomarkers at home. The company also offers sound-based stimulation synchronized to brain activity to enhance slow-wave sleep and memory consolidation.
Founders & leadership
NeuroGeneces was founded in 2021 by Karen Crow.
Investors · 1
Reported raises · per SEC filings
Form D private placements$555K disclosed across 2 of 3 rounds · 2018–2025
▶$425KraisedMay 2026 · 13 investors · Other Health CareRule 506(b)
- Karen CrowExecutive Officer, Director
- Barry Jason WorchelExecutive Officer, Director
- Offering amount
- $750K
- Amount sold
- $425K
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$130KraisedJan 2019 · 4 investors · BiotechnologyRule 506(b)
- Barry Jason WorchelExecutive Officer, Director, Promoter
- Karen CrowExecutive Officer, Director, Promoter
- Offering amount
- $1M
- Amount sold
- $130K
- Minimum investment
- $1
- First sale
- Jan 2018
- Incorporated
- Limited Liability Company, New Mexico, 2016
- Federal exemptions
- 04, 06b, 4a5
▶Undisclosed amountofferedApr 2018 · 1 investors · BiotechnologyRule 506(b)
- Barry Jason WorchelExecutive Officer, Director, Promoter
- Karen CrowExecutive Officer, Director, Promoter
- Minimum investment
- $1
- First sale
- Jan 2018
- Incorporated
- Limited Liability Company, New Mexico, 2016
- Federal exemptions
- 04, 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2023 | $295K |
| U.S. Air ForceAir Force | Phase IISTTR | 2022 | $750K |
| National Science Foundation | Phase I | 2022 | $255.7K |
| U.S. Air ForceAir Force | Phase ISTTR | 2022 | $49.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does NeuroGeneces do?
- NeuroGevity develops a sleep headband with biometric sensors and AI algorithms to assess brain health and detect neurophysiological biomarkers at home. The company also offers sound-based stimulation synchronized to brain activity to enhance slow-wave sleep and memory consolidation.
- Who founded NeuroGeneces?
- NeuroGeneces was founded by Karen Crow in 2021.
- Who are NeuroGeneces's investors?
- NeuroGeneces's investors include Techstars.
- How much funding has NeuroGeneces raised?
- NeuroGeneces has disclosed $555K raised across 2 of its 3 known rounds.
- Where is NeuroGeneces headquartered?
- NeuroGeneces is headquartered in Santa Fe, US.